{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T14:48:31Z","timestamp":1777819711033,"version":"3.51.4"},"reference-count":27,"publisher":"International Society of Endovascular Specialists","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endovascular Therapy"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1583\/08-2453.1","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T11:18:51Z","timestamp":1223378331000},"page":"570-579","source":"Crossref","is-referenced-by-count":31,"title":["Dethrombosis of the Lower Extremity Arteries Using the Power-Pulse Spray Technique in Patients with Recent Onset Thrombotic Occlusions:\n                    <b>Results of the DETHROMBOSIS Registry<\/b>"],"prefix":"10.1583","volume":"15","author":[{"given":"Nicolas W.","family":"Shammas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Shammas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Coiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Jerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"527","reference":[{"key":"i1545-1550-15-5-570-b1","doi-asserted-by":"crossref","unstructured":"N. W. Shammas, and E. J. Dippel .Evidence-based management of peripheral vascular disease., Curr Atheroscler Rep, 2005 .7 :358 \u2013863 .","DOI":"10.1007\/s11883-005-0047-8"},{"key":"i1545-1550-15-5-570-b2","unstructured":"N. W. Shammas, Dethrombosis of the lower extremities. Pharmacologic and mechanical techniques., Vasc Dis Manage, 2006 .May\/June :235 \u2013239 ."},{"key":"i1545-1550-15-5-570-b3","doi-asserted-by":"crossref","unstructured":"K. Ouriel, C. K. Shortell, and J. A. DeWeese .et al.A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia., J Vasc Surg, 1994 .19 :1021 \u20131030 .","DOI":"10.1016\/S0741-5214(94)70214-4"},{"key":"i1545-1550-15-5-570-b4","doi-asserted-by":"crossref","unstructured":"K. Ouriel, F. J. Veith, and A. A. Sasahara .Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators., J Vasc Surg, 1996 .23 :64 \u201373 .","DOI":"10.1016\/S0741-5214(05)80036-9"},{"key":"i1545-1550-15-5-570-b5","doi-asserted-by":"crossref","unstructured":"F. A. Weaver, A. J. Comerota, and M. Youngblood .et al.Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity., J Vasc Surg, 1996 .24 :513 \u2013521 .","DOI":"10.1016\/S0741-5214(96)70067-8"},{"key":"i1545-1550-15-5-570-b6","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, B. S. George, and C. F. Botti .et al.Rheolytic thrombectomy in the management of limb ischemia: 30-day results from a multicenter registry., J Endovasc Ther, 2002 .9 :395 \u2013402 .","DOI":"10.1177\/152660280200900402"},{"key":"i1545-1550-15-5-570-b7","doi-asserted-by":"crossref","unstructured":"D. E. Allie, C. J. Hebert, and M. D. Lirtzman .et al.Novel simultaneous combination chemical thrombolysis\/rheolytic thrombectomy therapy for acute critical limb ischemia: the power-pulse spray technique., Catheter Cardiovasc Interv, 2004 .63 :512 \u2013522 .","DOI":"10.1002\/ccd.20216"},{"key":"i1545-1550-15-5-570-b8","doi-asserted-by":"crossref","unstructured":"E. Rossi, L. M. Biasucci, and F. Citterio .et al.Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein., Circulation, 2002 .105 :800 \u2013803 .","DOI":"10.1161\/hc0702.104126"},{"key":"i1545-1550-15-5-570-b9","doi-asserted-by":"crossref","unstructured":"P. M. Ridker, M. J. Stampfer, and N. Rifai .Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease., JAMA, 2001 .285 :2481 \u20132485 .","DOI":"10.1001\/jama.285.19.2481"},{"key":"i1545-1550-15-5-570-b10","doi-asserted-by":"crossref","unstructured":"P. M. Gorter, J. K. Olijhoek, and Y. van der Graaf .et al.Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm., Atherosclerosis, 2004 .173 :363 \u2013369 .","DOI":"10.1016\/j.atherosclerosis.2003.12.033"},{"key":"i1545-1550-15-5-570-b11","doi-asserted-by":"publisher","DOI":"10.1583\/08-2397.1"},{"key":"i1545-1550-15-5-570-b12","doi-asserted-by":"crossref","unstructured":"K. Kasirajan, Z. J. Haskal, and K. Ouriel .The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease., J Vasc Interv Radiol, 2001 .12 :405 \u2013411 .","DOI":"10.1016\/S1051-0443(07)61877-6"},{"key":"i1545-1550-15-5-570-b13","doi-asserted-by":"crossref","unstructured":"M. H. Wholey, M. A. Maynar, and M. H. Wholey .et al.Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions., Cathet Cardiovasc Diagn, 1998 .44 :159 \u2013169 .","DOI":"10.1002\/(SICI)1097-0304(199806)44:2<159::AID-CCD8>3.0.CO;2-5"},{"key":"i1545-1550-15-5-570-b14","doi-asserted-by":"crossref","unstructured":"D. Siablis, D. Karnabatidis, and K. Katsanos .et al.Outflow protection filters during percutaneous recanalization of lower extremities' arterial occlusions: a pilot study., Eur J Radiol, 2005 .55 :243 \u2013249 .","DOI":"10.1016\/j.ejrad.2004.07.010"},{"key":"i1545-1550-15-5-570-b15","doi-asserted-by":"crossref","unstructured":"R. Suri, M. H. Wholey, and D. Postoak .et al.Distal embolic protection during femoropopliteal atherectomy., Catheter Cardiovasc Interv, 2006 .67 :417 \u2013422 .","DOI":"10.1002\/ccd.20634"},{"key":"i1545-1550-15-5-570-b16","doi-asserted-by":"crossref","unstructured":"D. Karnabatidis, K. Katsanos, and G. C. Kagadis .et al.Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon., J Endovasc Ther, 2006 .13 :269 \u2013280 .","DOI":"10.1583\/05-1771.1"},{"key":"i1545-1550-15-5-570-b17","unstructured":"N. W. Shammas, Embolization in lower extremity percutaneous interventions: recommendations and strategies for embolic filter protection use., Vasc Dis Manage, 2008 .5 :22 \u201326 ."},{"key":"i1545-1550-15-5-570-b18","doi-asserted-by":"crossref","unstructured":"N. W. Shammas, Bivalirudin: pharmacology and clinical applications., Cardiovasc Drug Rev, 2005 .23 :345 \u2013360 .","DOI":"10.1111\/j.1527-3466.2005.tb00177.x"},{"key":"i1545-1550-15-5-570-b19","doi-asserted-by":"crossref","unstructured":"A. M. Lincoff, J. A. Bittl, and N. S. Kleiman .et al.Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)., Am J Cardiol, 2004 .93 :1092 \u20131096 .","DOI":"10.1016\/j.amjcard.2004.01.033"},{"key":"i1545-1550-15-5-570-b20","unstructured":"D. E. Allie, C. J. Hebert, and M. D. Lirtzman .et al.A safety and feasibility report of combined direct thrombin and GP IIb\/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome., J Invasive Cardiol, 2005 .17 :427 \u2013432 ."},{"key":"i1545-1550-15-5-570-b21","doi-asserted-by":"crossref","unstructured":"J. K. French, J. J. Edmond, and W. Gao .et al.Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction., Am J Cardiovasc Drugs, 2004 .4 :107 \u2013115 .","DOI":"10.2165\/00129784-200404020-00004"},{"key":"i1545-1550-15-5-570-b22","doi-asserted-by":"crossref","unstructured":"A. M. Lincoff, J. A. Bittl, and R. A. Harrington .Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa during percutaneous coronary intervention; the REPLACE-2 randomized trial., JAMA, 2003 .289 :853 \u2013863 .","DOI":"10.1001\/jama.289.7.853"},{"key":"i1545-1550-15-5-570-b23","unstructured":"D. E. Allie, M. D. Lirtzman, and C. H. Wyatt .et al.Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions., J Invasive Cardiol, 2003 .15 :334 \u2013342 ."},{"key":"i1545-1550-15-5-570-b24","unstructured":"N. W. Shammas, J. H. Lemke, and E. J. Dippel .et al.Bivalirudin in peripheral vascular interventions: a single center experience., J Invasive Cardiol, 2003 .15 :401 \u2013404 ."},{"key":"i1545-1550-15-5-570-b25","unstructured":"D. E. Allie, P. Hall, and N. W. Shammas .et al.The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): in-hospital and 30-day results., J Invasive Cardiol, 2004 .16 :651 \u2013656 ."},{"key":"i1545-1550-15-5-570-b26","doi-asserted-by":"crossref","unstructured":"S. H. Duda, G. Tepe, and O. Luz .et al.Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone-a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis., Radiology, 2001 .221 :689 \u2013696 .","DOI":"10.1148\/radiol.2213010400"},{"key":"i1545-1550-15-5-570-b27","doi-asserted-by":"crossref","unstructured":"D. E. Allie, C. J. Hebert, and M. D. Lirtzman .et al.Continuous tenecteplase infusion combined with peri\/postprocedural platelet glycoprotein IIb\/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience., J Endovasc Ther, 2004 .11 :427 \u2013435 .","DOI":"10.1583\/03-1170.1"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:28:53Z","timestamp":1777498133000},"score":1,"resource":{"primary":{"URL":"http:\/\/jet.sagepub.com\/lookup\/doi\/10.1583\/08-2453.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1583\/08-2453.1"],"URL":"https:\/\/doi.org\/10.1583\/08-2453.1","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}